Local News: Conshohocken, PA 

 | 

Sign Up

 | 

Sign In

Advertisment

Lantus, Insulin Glargine

Lantus, Insulin Glargine News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Lantus, Insulin Glargine News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Lantus, Insulin Glargine News

News on Lantus, Insulin Glargine (generic) continually updated from thousands of sources around the net.

Monday Oct 26 | Malta Today

Diabetes sufferers to finally get free insulin pens

The social policy ministry is expected to rectify a long-standing, and painful issue for sufferers of diabetes.

Comment?

Related Topix: Insulin (generic), Humulin, Novolin, Medicine, Medication, Health, Diabetes

Thu Oct 22, 2009

BioWorld

Wellstat, Sanofi Ink $350M Deal for Phase II Insulin Sensitizer

Privately held Wellstat Therapeutics Corp. stands to gain up to $350 million, including an undisclosed up-front payment, in exchange for global rights to its Type II diabetes oral insulin sensitizer PN2034 and related compounds in a development and commercialization deal with Sanofi-Aventis Group SA, which sought the licensing agreement to beef up ...

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, Diabetes, Health, Gaithersburg, MD

Wed Oct 21, 2009

Drugs.com

Sanofi-Aventis and Wellstat Therapeutics Enter into an Exclusive...

Paris, October 21, 2009 Sanofi-aventis and Wellstat Therapeutics Corporation announced today a global licensing agreement on PN2034, a novel oral first-in-class, insulin sensitizer, for the treatment of Type II Diabetes.

Comment?

Related Topix: Biotech, SanofiSynthlabo, Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Gaithersburg, MD

Tue Oct 20, 2009

Drugs.com

Data Analysis Reinforces the Safety Profile of Levemir

A meta-analysis of clinical data published today in Diabetologia, the medical journal for the European Association for the Study of Diabetes , demonstrated that the Novo Nordisk long-acting insulin Levemir was not associated with any increase in the incidence of cancer when compared to human insulin .

Comment?

Related Topix: Insulin (generic), Humulin, Novolin, Medicine, Medication, Health, Diabetes

Thu Oct 15, 2009

BioResearch Online

Biosimilar Insulins And Insulin Analogues Stand To Erode $6.1B...

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilar insulins and insulin analogues stand to erode $6.1B in brand sales in the U.S. and Europe by 2018, saving healthcare systems $3.8B in the process.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Insulin (generic), Humulin, Novolin, Medication, Endocrinology, Diabetes, Health

Thu Oct 08, 2009

CBC

Drug coverage based on cost, effectiveness works: study

Provincial drug plans often follow the coverage recommendations of Canada's Common Drug Review board.

Comment?

Related Topix: Canada, Medicine, Medication, Diabetes

Tue Oct 06, 2009

M2.com

Novo Nordisk reports study data for NovoMix 30 in Type 2 diabetes patients

Findings demonstrate that Type 2 diabetes patients starting insulin treatment with once-daily injection of NovoMix 30 achieve a significantly greater HbA reduction compared to patients starting with a daily injection of insulin glargine.

Comment?

Related Topix: Medicine, Health, Diabetes, Insulin (generic), Humulin, Novolin, Medication

Sun Oct 04, 2009

Drugs.com

Superior Efficacy-dose Ratio for Lantus Over detemir

Sanofi-aventis announced today results of a head-to-head study providing further evidence on the efficacy of once-daily, 24-hour basal insulin Lantus compared to twice-daily insulin detemir.

Comment?

Related Topix: Medicine, Medication, Insulin (generic), Humulin, Novolin, Biotech, SanofiSynthlabo, Diabetes, Health

Fri Oct 02, 2009

In Diabetes Today

Levemir Does Not Increase Risk of Cancer: Studies

Novo Nordisk's Levemir was not associated in any increase in incidence of cancer when compared with human insulin in studies including some 9,000 patients, according to a new analysis released on Thursday.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, Diabetes, Health

Drug Store News

Report: Doctors to examine possible link between diabetes, cancer

NEW YORK Possible links between a popular brand of insulin and cancer have prompted doctors to investigate, according to published reports.

Comment?

Related Topix: Medicine, Diabetes, New York Metro, Health, Insulin (generic), Humulin, Novolin, Medication

Wed Sep 30, 2009

Bloomberg Business News

Cancer Alert Explored as Sanofi, Novo Diabetes Drugs Scrutinized in Vienna

Doctors will try to unravel possible ties between diabetes treatments and cancer this week after studies indicated that medicines used by millions of people may leave some vulnerable to tumors.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Novo Nordisk AS, Insulin (generic), Humulin, Novolin, Medication, SanofiSynthlabo, Thyroid Cancer

Tue Sep 29, 2009

Fox News

Sanofi-Aventis To Launch Insulin Research Program

French drugmaker Sanofi-Aventis said Tuesday that it is planning to undertake methodologically robust research that will contribute to the scientific resolution of the debate over insulin safety, including insulin analogs and its Lantus drug.

Comment?

Related Topix: Biotech, SanofiSynthlabo, Medicine, Medication, Business News

Sun Sep 27, 2009

CiteULike

Effects of Initiating Insulin and Metformin on Glycemic Control and...

Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial Export JAMA , Vol.

Comment?

Related Topix: Medicine, Metformin (generic), Glucophage, Medication, Insulin (generic), Humulin, Novolin, Diabetes, Health

Fri Sep 25, 2009

Diabetes Mine - the all things diabet...

Test Driving Insulin

"What a wonderful book! Diabetes can feel confusing and overwhelming, but it doesn't have to be a ' especially thanks to books like this." a ' Dr.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, Diabetes, Health, Humalog, Insulin Lispro (generic)

Wed Sep 23, 2009

Scoop

No evidence for insulin glargine cancer risk

Thursday, 24 September 2009, 11:29 am Press Release: Ministry of Health No conclusive evidence linking insulin glargine to higher cancer risk Medicines regulatory authorities in New Zealand have found no conclusive evidence that the use of insulin glargine is associated with increased risk of developing cancer, saying findings of recent studies may ...

Comment?

Related Topix: Medicine, Medication, Health, Diabetes, Insulin (generic), Humulin, Novolin

Mon Sep 21, 2009

HealthCentral

Icon_sharepost

I don't eat bread, pasta, cereals, potatoes, yet my A1C is 9 or above. I don't eat bread, pasta, cereals, potatoes, yet my A1C is 9 or above.

Comment?

Related Topix: Medicine, Medication, Health, Diabetes

Sat Sep 19, 2009

Archives General Psychiatry

Original Contribution: Effects of Initiating Insulin and Metformin on ...

Context As diabetes is in part an inflammatory condition, the initiation of insulin and/or metformin may beneficially reduce levels of inflammatory biomarkers such as high-sensitivity C-reactive protein .

Comment?

Related Topix: Metformin (generic), Glucophage, Medication, Insulin (generic), Humulin, Novolin, Diabetes, Health

Thu Sep 17, 2009

Express India

Biocon takes regulator to court over insulin pricing

Soma Das Posted: Wednesday, Sep 16, 2009 at 0144 hrs IST Updated: Wednesday, Sep 16, 2009 at 0144 hrs IST New Delhi: Biocon Ltd, the Rs 1,600-crore biotech firm, has locked horns with the drug price regulator, the National Pharmaceutical Pricing Authority, challenging the NPPA decision to fix and monitor the price of its recent diabetes ...

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, World News, India, Biotech, Science / Technology, Diabetes, Health, SanofiSynthlabo

Tue Sep 15, 2009

HealthDay

Diabetes Medications Don't Lower Inflammation

In people with newly diagnosed type 2 diabetes, the glucose-lowering medications metformin and insulin don't appear to reduce the inflammation associated with heart disease, new research suggests.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, Metformin (generic), Glucophage, Hospital Administration, Healthcare Industry

Sat Sep 05, 2009

Leader Post

Long-acting insulin substitute approved

The Ministry of Health has added a long-acting insulin substitute to its list of approved drugs.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health

Also on Topix